Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

24 terminated/withdrawn out of 241 trials

Success Rate

82.9%

-3.6% vs industry average

Late-Stage Pipeline

8%

19 trials in Phase 3/4

Results Transparency

36%

42 of 116 completed trials have results

Key Signals

56 recruiting42 with results12 terminated12 withdrawn

Enrollment Performance

Analytics

N/A
95(53.7%)
Phase 2
31(17.5%)
Phase 1
28(15.8%)
Phase 3
12(6.8%)
Phase 4
7(4.0%)
Early Phase 1
4(2.3%)
177Total
N/A(95)
Phase 2(31)
Phase 1(28)
Phase 3(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (241)

Showing 20 of 241 trials
NCT06892158Not ApplicableRecruiting

Massage Impact on Sleep in Pediatric Oncology

Role: collaborator

NCT00001403Recruiting

Study of Proteus Syndrome and Related Congenital Disorders

Role: collaborator

NCT06907173Phase 3Recruiting

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Role: collaborator

NCT06065228Recruiting

Therapeutic Endpoint in Pediatric IBD Conditions

Role: lead

NCT04992299Not ApplicableCompleted

Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents

Role: collaborator

NCT06194747Not ApplicableRecruiting

Improving Status Epilepticus Treatment Times

Role: collaborator

NCT03822442Completed

MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients

Role: lead

NCT05697874Recruiting

International Rare Brain Tumor Registry

Role: lead

NCT00018044Recruiting

Study of Mycobacterial Infections

Role: collaborator

NCT06548022Not ApplicableCompleted

Rare Group Problem Management Plus

Role: lead

NCT04975698Phase 2Completed

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

Role: collaborator

NCT02789228Phase 1Active Not Recruiting

Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors

Role: lead

NCT03180216Phase 1Active Not Recruiting

T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation

Role: lead

NCT04372875Not ApplicableRecruiting

Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial

Role: lead

NCT06014879Not ApplicableRecruiting

EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes

Role: collaborator

NCT05141058Phase 1Recruiting

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

Role: lead

NCT05238792Phase 1Recruiting

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Role: lead

NCT06193759Phase 1Recruiting

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Role: lead

NCT04102371Phase 3Completed

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Role: collaborator

NCT06313398Early Phase 1Recruiting

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Role: collaborator